Ainos Inc. (NASDAQ: AIMD)
$0.79
-0.0055 ( -0.69% ) 126.9K
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
Market Data
Open
$0.79
Previous close
$0.80
Volume
126.9K
Market cap
$5.20M
Day range
$0.78 - $0.81
52 week range
$0.77 - $5.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 12, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
10-q | Quarterly Reports | 62 | May 13, 2024 |
3 | Insider transactions | 1 | May 08, 2024 |
8-k | 8K-related | 18 | May 06, 2024 |
3 | Insider transactions | 2 | Mar 19, 2024 |
8-k | 8K-related | 23 | Mar 19, 2024 |
8-k | 8K-related | 16 | Mar 15, 2024 |
10-k | Annual reports | 91 | Mar 08, 2024 |